Prosecution Insights
Last updated: August 16, 2026

Beth Israel Deaconess Medical Center Inc.

18 pending office actions • 17 art units • 18 examiners • 0 of 18 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Portfolio Summary

18
Total Pending OAs
11
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (44%)
8
Medium (44%)
2
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (6%)
§103 only7 (39%)
§112 only1 (6%)
Double-patenting only1 (6%)
Double-patenting + other1 (6%)
Multi-statute (no §101)7 (39%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
67% of docket
0
Information Tech
0% of docket
1
Communications
6% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
22% of docket
1
Business / Other
6% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

180 h
Manual time on pending OAs
36 h
Time saved (low, 20%)
63 h
Time saved (mid, 35%)
1.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PYLA, EVELYN Y 1 55.7% +47.6%
SUN, CAITLYN MINGYUN 1 63.6% +11.1%
WORSHAM, JESSICA N 1 56.4% +56.6%
WU, PAMELA F 1 58.0% +21.4%
HAWTHORNE, OPHELIA ALTHEA 1 71.9% +30.3%
LEE, JIA-HAI 1 49.8% +48.0%
CHONG, KIMBERLY 1 72.4% +12.8%
YANG, YI-SHAN 1 70.0% +54.4%
MCCORMICK, CATHERINE LYNN 1 48.8% +35.6%
JANSSEN, REBECCA 1 59.8% +30.6%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18014561 COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS GOMEZ RODRIGUEZ, JULIO WASHINGTON 131d overdue
17887096 SYSTEM AND METHOD FOR IMPROVING SHARPNESS OF MAGNETIC RESONANCE IMAGES USING A DEEP LEARNING NEURAL NETWORK LU, ZHIYU 73d overdue
16324945 A20 THERAPY TO ACHIEVE GLYCEMIC CONTROL SHIN, DANA H 15d
17133277 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS GEIGER, RACHAEL L 29d
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA
18096246 EXTERNAL FIXATION CLAMP AND SYSTEMS FOR MEDICAL PROCEDURES JANSSEN, REBECCA
17781989 METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN FLINDERS, JEREMY C
17291723 METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z PULLIAM, JOSEPH CONSTANTINE

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17926040 METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE WORSHAM, JESSICA N 44d overdue
18274028 ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION SUN, CAITLYN MINGYUN 30d overdue
18036455 SYSTEMS AND METHODS FOR IMPROVING SLEEP AND OTHER INDICATIONS, INCLUDING TREATING ANXIETY YANG, YI-SHAN 23d overdue
18771037 SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING PYLA, EVELYN Y
15844440 LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION WU, PAMELA F
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA
18272092 PEGYLATED P-SELECTIN INHIBITORS LEE, JIA-HAI
18321971 OPTIMIZED ANTI-FLT1 OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS CHONG, KIMBERLY

Top Art Units

Art UnitApps
1795 1
1615 1
3795 1
3786 1
1658 1
1636 1
3798 1
1638 1
1733 1
1637 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18771037 SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING PYLA, EVELYN Y DP Non-Final OA Pending Jul 12, 2024
18274028 ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA 30d overdue Pending Jul 25, 2023
17926040 METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE WORSHAM, JESSICA N 1615 §103 Non-Final OA 44d overdue Pending Nov 17, 2022
15844440 LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION WU, PAMELA F 3795 §103 Non-Final OA Pending Dec 15, 2017
18726658 THERMALLY ACTIVATED PESSARY HAWTHORNE, OPHELIA ALTHEA 3786 §102§103 Non-Final OA Pending Jul 03, 2024
18272092 PEGYLATED P-SELECTIN INHIBITORS LEE, JIA-HAI 1658 §103DP Final Rejection Pending Jul 12, 2023
18321971 OPTIMIZED ANTI-FLT1 OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS CHONG, KIMBERLY 1636 §112 Non-Final OA Pending May 23, 2023
18036455 SYSTEMS AND METHODS FOR IMPROVING SLEEP AND OTHER INDICATIONS, INCLUDING TREATING ANXIETY YANG, YI-SHAN 3798 §103 Non-Final OA 23d overdue Pending May 11, 2023
18041271 ANTI-SEED PNAS AND MICRORNA INHIBITION MCCORMICK, CATHERINE LYNN 1638 §103 Final Rejection Pending Feb 10, 2023
18096246 EXTERNAL FIXATION CLAMP AND SYSTEMS FOR MEDICAL PROCEDURES JANSSEN, REBECCA 1733 §103§112 Non-Final OA Pending Jan 12, 2023
18014561 COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 §103§112 Non-Final OA 131d overdue Pending Jan 05, 2023
17887096 SYSTEM AND METHOD FOR IMPROVING SHARPNESS OF MAGNETIC RESONANCE IMAGES USING A DEEP LEARNING NEURAL NETWORK LU, ZHIYU 2665 §103§112 Final Rejection 73d overdue Pending Aug 12, 2022
17783180 COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT TRAN, CHAU NGUYEN BICH 1677 §103 Final Rejection Pending Jun 07, 2022
17781989 METHODS FOR DUAL DNA/PROTEIN TAGGING OF OPEN CHROMATIN FLINDERS, JEREMY C 1684 §102§112 Non-Final OA Pending Jun 02, 2022
17291723 METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z PULLIAM, JOSEPH CONSTANTINE 1687 §101 Final Rejection Pending May 06, 2021
17250791 METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF TRAN, KHOA NHAT 1632 §103 Final Rejection Pending Mar 04, 2021
17133277 LYMPHATIC ANASTOMOSIS DEVICES AND METHODS GEIGER, RACHAEL L 3771 §102§103 Non-Final OA 29d Pending Dec 23, 2020
16324945 A20 THERAPY TO ACHIEVE GLYCEMIC CONTROL SHIN, DANA H 1635 §103§112 Final Rejection 15d Pending Feb 12, 2019

Managing Beth Israel Deaconess Medical Center Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month